Area of research
Biomaterials · Pharmaceutical Science
Research interest
Research interests include Nanoparticle-Based Drug Delivery, Advanced Drug Delivery Systems, Nanoplatforms for cancer theranostics, and RNA Interference and Gene Delivery.
Surface hydrophobicity and rigidity determines protein corona on orally delivered nanoparticles treating colitis
Targeting mitocytosis potentiates mitochondria drug delivery for antimetastasis therapy
Dual‐Scale Targeting of Myofibroblasts and Mitochondria via Oral Cascade Delivery Systems Alleviate Intestinal Fibrosis
Intercellular NETwork-facilitated sarcoplasmic reticulum targeting for myocardial ischemia-reperfusion injury treatment
Enhance Efferocytosis and Block the Macrophages–Platelets Feedback Loop for Targeted Treatment of Psoriasis
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases
Harnessing Surface Hydrophilicity of Inhalable Nanoparticles for Precision Delivery of Glucagon-like Peptide-1 Receptor Agonists or Anti-Asthmatic Therapeutics
Identifying adverse nodal features associated with poor prognosis in stage IB nasopharyngeal carcinoma patients based on the 9th AJCC/UICC staging system: Implications for treatment intensification
A nano-system combines mitochondrial damage with microtubule stabilization for cancer metastasis suppression
Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation
A Two-Pronged Delivery Strategy Disrupting Positive Feedback Loop of Neutrophil Extracellular Traps for Metastasis Suppression
A Less‐is‐More Strategy for Mitochondria‐Targeted Photodynamic Therapy of Rheumatoid Arthritis
Large-scale proteomic analyses of incident Alzheimer’s disease reveal new pathophysiological insights and potential therapeutic targets
Cellular Uptake and Transport Mechanism Investigations of PEGylated Niosomes for Improving the Oral Delivery of Thymopentin
Counteracting Alzheimer's disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator
Lipoic acid-mediated oral drug delivery system utilizing changes on cell surface thiol expression for the treatment of diabetes and inflammatory diseases
Durable Attenuation of Tumor pH–Platelet Linkage Reinstates Bioorthogonal Targeting of Residual Tumors Post-Debulking
Escape sites from the endo-lysosomal trafficking route manipulate exocytosis of nanoparticles in polar epithelium
Biomimetic nanoparticle synchronizing pyroptosis induction and mitophagy inhibition for anti-tumor therapy
Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis
Disease-specific protein corona formed in pathological intestine enhances the oral absorption of nanoparticles
Modulation of Autophagy Direction to Enhance Antitumor Effect of Endoplasmic‐Reticulum‐Targeted Therapy: Left or Right?
Butyrate Modification Promotes Intestinal Absorption and Hepatic Cancer Cells Targeting of Ferroptosis Inducer Loaded Nanoparticle for Enhanced Hepatocellular Carcinoma Therapy
Enhance Mitochondrial Damage by Nuclear Export Inhibition to Suppress Tumor Growth and Metastasis with Increased Antitumor Properties of Macrophages
Strategies to Enhance Drug Permeability across Biological Barriers—A Summary of This Important Special Issue
Milk-derived exosomes exhibit versatile effects for improved oral drug delivery.
Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade
Immunogenic hydrogel toolkit disturbing residual tumor “seeds” and pre-metastatic “soil” for inhibition of postoperative tumor recurrence and metastasis
Exocytosis blockade of endoplasmic reticulum-targeted nanoparticle enhances immunotherapy
Trauma-Responsive Scaffold Synchronizing Oncolysis Immunization and Inflammation Alleviation for Post-Operative Suppression of Cancer Metastasis